查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451616

2024-2032 年按产品、年龄层、配销通路和地区分類的避孕药物市场报告

Contraceptive Drugs Market Report by Product, Age Group, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

2023年全球避孕药市场规模达到158亿美元。展望未来， IMARC Group预计到2032年市场规模将达到245亿美元，2024-2032年复合年增长率（CAGR）为4.9%。

避孕药是指用于预防怀孕、控制生育率的避孕药物。它们是使用两种雌激素（即雌激素和黄体素）合成配製而成，可防止排卵。这些荷尔蒙也会使子宫颈黏液变稠或改变子宫内膜，以阻止精子进入子宫颈进行受精和植入。避孕药有助于降低痤疮、骨质疏鬆、卵巢癌、输卵管和子宫感染以及经前症候群 (PMS) 的风险。因此，医疗保健从业人员会使用这些药物来抑制育龄妇女意外怀孕。目前，它们主要有口服、注射和外用製剂。

避孕药市场趋势：

推动全球避孕药市场的关键因素之一是消费者对计划生育意识的提高、人口的增加以及意外怀孕事件的增加。与此一致的是，由于现代避孕方法具有多种好处，包括最佳的安全性和更好的临床结果，医疗保健从业人员对现代避孕方法的倾向转变为传统避孕方法的另一个促进因素。此外，食品药物管理局（FDA）等多个监管机构经常批准新药，也支持了市场的成长。此外，明胶胶囊和非荷尔蒙阴道凝胶的出现，透过维持阴道 pH 水平，为精子创造了一个不适合生存的环境，这也推动了市场的成长。除此之外，持续的研发（R＆D）活动以及非政府组织（NGO）和卫生机构为提高消费者对避孕技术、妇女健康和性健康的认识而采取的有利倡议，正在积极促进市场成长。

本报告回答的关键问题

  • 2023年全球避孕药市场规模有多大？
  • 2024-2032年全球避孕药市场的预期成长率是多少？
  • 推动全球避孕药市场的关键因素是什么？
  • COVID-19 对全球避孕药市场有何影响？
  • 基于该产品的全球避孕药市场的细分情况如何？
  • 全球避孕药市场依年龄层划分情况如何？
  • 全球避孕药市场的配销通路划分如何？
  • 全球避孕药市场的重点区域有哪些？
  • 全球避孕药市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球避孕药市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 口服避孕药
    • 市场走向
    • 市场预测
  • 注射避孕药
    • 市场走向
    • 市场预测
  • 外用避孕药
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依年龄段

  • 15-24岁
    • 市场走向
    • 市场预测
  • 25-34岁
    • 市场走向
    • 市场预测
  • 35-44岁
    • 市场走向
    • 市场预测
  • 44岁以上
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按配销通路

  • 零售药房
    • 市场走向
    • 市场预测
  • 医院药房
    • 市场走向
    • 市场预测
  • 诊所
    • 市场走向
    • 市场预测
  • 线上通路
    • 市场走向
    • 市场预测
  • 公共管道和非政府组织
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AbbVie Inc.
    • Afaxys Inc.
    • Agile Therapeutics
    • Amneal Pharmaceuticals Inc.
    • Bayer AG
    • Johnson & Johnson
    • Mithra Pharmaceuticals SA
    • Novartis AG
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Viatris Inc.
Product Code: SR112024A6300

The global contraceptive drugs market size reached US$ 15.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.9% during 2024-2032.

Contraceptive drugs refer to birth control medications that are used to prevent pregnancy and control the birth rate. They are synthetically formulated using two female hormones, namely estrogen and progestin, which prevent ovulation. These hormones also thicken cervical mucus or alter the womb lining to prohibit the entrance of sperm into the cervix for fertilization and implantation. Contraceptive drugs assist in lowering the risks of acne, bone thinning, ovarian cancer, infections in the fallopian tubes and uterus, and premenstrual syndrome (PMS). As a result, they are administered by healthcare practitioners to inhibit unwanted pregnancy amongst women of childbearing age. At present, they are mainly available in oral, injectable, and topical formulations.

Contraceptive Drugs Market Trends:

One of the key factors driving the global contraceptive drugs market is the rising consumer consciousness regarding family planning, the increasing population, and the rising instances of unintended pregnancies. In line with this, the shifting inclination of healthcare practitioners toward modern contraceptive methods over conventional procedures, owing to their multiple benefits, including optimal safety, and better clinical outcomes, are acting as another growth-inducing factor. Additionally, the frequent approvals of novel medications by several regulatory bodies, such as the food and drug administration (FDA), are supporting the market growth. Moreover, the advent of gelatin capsules and non-hormonal vaginal gels that create an inhospitable environment for sperm to sustain by maintaining vagina pH levels is impelling the market growth. Apart from this, continuous research and development (R&D) activities and the favorable initiatives undertaken by non-governmental organizations (NGOs) and health agencies to sensitize consumers about contraception techniques, women's health, and sexual wellness are positively augmenting the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global contraceptive drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, age group and distribution channel.

Breakup by Product:

Oral Contraceptive Pills

Injectable Contraceptives

Topical Contraceptives

Breakup by Age Group:

15-24 years

25-34 years

35-44 years

Above 44 years

Breakup by Distribution Channel:

Retail Pharmacy

Hospital Pharmacy

Clinics

Online Channel

Public Channel and NGOs

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Afaxys Inc., Agile Therapeutics, Amneal Pharmaceuticals Inc., Bayer AG, Johnson & Johnson, Mithra Pharmaceuticals SA, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd. and Viatris Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global contraceptive drugs market in 2023?
  • 2. What is the expected growth rate of the global contraceptive drugs market during 2024-2032?
  • 3. What are the key factors driving the global contraceptive drugs market?
  • 4. What has been the impact of COVID-19 on the global contraceptive drugs market?
  • 5. What is the breakup of the global contraceptive drugs market based on the product?
  • 6. What is the breakup of the global contraceptive drugs market based on the age group?
  • 7. What is the breakup of the global contraceptive drugs market based on the distribution channel?
  • 8. What are the key regions in the global contraceptive drugs market?
  • 9. Who are the key players/companies in the global contraceptive drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Contraceptive Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Oral Contraceptive Pills
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Injectable Contraceptives
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Topical Contraceptives
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Age Group

  • 7.1 15-24 years
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 25-34 years
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 35-44 years
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Above 44 years
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Retail Pharmacy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospital Pharmacy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Online Channel
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Public Channel and NGOs
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AbbVie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Afaxys Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Agile Therapeutics
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Amneal Pharmaceuticals Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Bayer AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Johnson & Johnson
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Mithra Pharmaceuticals SA
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Novartis AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pfizer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Teva Pharmaceutical Industries Ltd.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Viatris Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials

List of Figures

  • Figure 1: Global: Contraceptive Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Contraceptive Drugs Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Contraceptive Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Contraceptive Drugs Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Contraceptive Drugs Market: Breakup by Age Group (in %), 2023
  • Figure 6: Global: Contraceptive Drugs Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Contraceptive Drugs Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Contraceptive Drugs (Oral Contraceptive Pills) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Contraceptive Drugs (Oral Contraceptive Pills) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Contraceptive Drugs (Injectable Contraceptives) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Contraceptive Drugs (Injectable Contraceptives) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Contraceptive Drugs (Topical Contraceptives) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Contraceptive Drugs (Topical Contraceptives) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Contraceptive Drugs (15-24 years) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Contraceptive Drugs (15-24 years) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Contraceptive Drugs (25-34 years) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Contraceptive Drugs (25-34 years) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Contraceptive Drugs (35-44 years) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Contraceptive Drugs (35-44 years) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Contraceptive Drugs (Above 44 years) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Contraceptive Drugs (Above 44 years) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Contraceptive Drugs (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Contraceptive Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Contraceptive Drugs (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Contraceptive Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Contraceptive Drugs (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Contraceptive Drugs (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Contraceptive Drugs (Online Channel) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Contraceptive Drugs (Online Channel) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Contraceptive Drugs (Public Channel and NGOs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Contraceptive Drugs (Public Channel and NGOs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Contraceptive Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Contraceptive Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: North America: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: North America: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: United States: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: United States: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Canada: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Canada: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Asia-Pacific: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Asia-Pacific: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: China: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: China: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Japan: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Japan: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: India: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: India: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: South Korea: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: South Korea: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Australia: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Australia: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Indonesia: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Indonesia: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Others: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Europe: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Europe: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Germany: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Germany: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: France: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: France: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: United Kingdom: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: United Kingdom: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Italy: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Italy: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Spain: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Spain: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Russia: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Russia: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Latin America: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Latin America: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Brazil: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Brazil: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Mexico: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Mexico: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Others: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Middle East and Africa: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Middle East and Africa: Contraceptive Drugs Market: Breakup by Country (in %), 2023
  • Figure 82: Middle East and Africa: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Global: Contraceptive Drugs Industry: SWOT Analysis
  • Figure 84: Global: Contraceptive Drugs Industry: Value Chain Analysis
  • Figure 85: Global: Contraceptive Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Contraceptive Drugs Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Contraceptive Drugs Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Contraceptive Drugs Market Forecast: Breakup by Age Group (in Million US$), 2024-2032
  • Table 4: Global: Contraceptive Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Contraceptive Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Contraceptive Drugs Market: Competitive Structure
  • Table 7: Global: Contraceptive Drugs Market: Key Players